Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
Figure 3
Biomarker concentrations in serum of patients with chronic kidney disease: (a) soluble mesothelin concentrations and (b) MPF concentrations as determined using assay from MBL. (Significant difference between indicated cohorts: *; ***.)